Kwangdong Pharmaceutical has formalized its artificial intelligence (AI) research and development (R&D) system and is expanding the application of AI across its operations and business sites. The company aims to broaden the scope of AI utilization from new material discovery to manufacturing, logistics, and distribution.
On October 26, Kwangdong Pharmaceutical announced that its in-house AI dedicated organization, the AI Center, has been recognized as a corporate research institute by the Korea Industrial Technology Promotion Association (KOITA).
The AI Center oversees the establishment of regulatory response systems for each business sector, the discovery of functional new materials, and the development of demand forecasting models. It is also pursuing research to apply AI technology to on-site operations, from product development to production, logistics, and distribution.
The company is also running a talent development program called 'AI Crew' to enhance the AI utilization capabilities of its employees. This year, the quality division of Kwangdong Pharmaceutical's production headquarters received the top award in the Gyeonggi Province preliminary round of the National Quality Innovation Competition and won a bronze medal in the national finals for big data and AI.
Kwangdong Pharmaceutical is concurrently advancing the digital transformation of its operational infrastructure. The company has adopted Google Workspace as a collaborative tool across the organization and has created an environment where employees can utilize generative AI 'Gemini.' It plans to gradually transition its internal email, messenger, and video conferencing systems to enhance collaboration efficiency.
Lee Seung-jae, head of the AI Center at Kwangdong Pharmaceutical, stated, "The recognition of the AI Center as a corporate research institute signifies the establishment of a systematic foundation for integrating AI-based data technology across the pharmaceutical and food and beverage sectors. We aim to build a sustainable digital innovation system by combining AI technology with the on-site application capabilities of our employees."
Meanwhile, Kwangdong Pharmaceutical, which is celebrating its 63rd anniversary this year, has outlined its direction to establish a long-term growth foundation based on sound management and social responsibility during a recent commemorative ceremony.
In his commemorative speech, CEO Choi Sung-won emphasized, "As a pharmaceutical company, we must transform into an enterprise that fulfills its social responsibilities based on our expertise and solid foundation. Let us use the history of challenge and innovation over the past 63 years as a stepping stone to move forward together toward the future from our respective positions."
On October 26, Kwangdong Pharmaceutical announced that its in-house AI dedicated organization, the AI Center, has been recognized as a corporate research institute by the Korea Industrial Technology Promotion Association (KOITA).
The AI Center oversees the establishment of regulatory response systems for each business sector, the discovery of functional new materials, and the development of demand forecasting models. It is also pursuing research to apply AI technology to on-site operations, from product development to production, logistics, and distribution.
The company is also running a talent development program called 'AI Crew' to enhance the AI utilization capabilities of its employees. This year, the quality division of Kwangdong Pharmaceutical's production headquarters received the top award in the Gyeonggi Province preliminary round of the National Quality Innovation Competition and won a bronze medal in the national finals for big data and AI.
Kwangdong Pharmaceutical is concurrently advancing the digital transformation of its operational infrastructure. The company has adopted Google Workspace as a collaborative tool across the organization and has created an environment where employees can utilize generative AI 'Gemini.' It plans to gradually transition its internal email, messenger, and video conferencing systems to enhance collaboration efficiency.
Lee Seung-jae, head of the AI Center at Kwangdong Pharmaceutical, stated, "The recognition of the AI Center as a corporate research institute signifies the establishment of a systematic foundation for integrating AI-based data technology across the pharmaceutical and food and beverage sectors. We aim to build a sustainable digital innovation system by combining AI technology with the on-site application capabilities of our employees."
Meanwhile, Kwangdong Pharmaceutical, which is celebrating its 63rd anniversary this year, has outlined its direction to establish a long-term growth foundation based on sound management and social responsibility during a recent commemorative ceremony.
In his commemorative speech, CEO Choi Sung-won emphasized, "As a pharmaceutical company, we must transform into an enterprise that fulfills its social responsibilities based on our expertise and solid foundation. Let us use the history of challenge and innovation over the past 63 years as a stepping stone to move forward together toward the future from our respective positions."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.